MB "Molecule projects" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 846,260 |
| - |
| 114,986 |
| 97,609 |
| - |
| 20.33 |
| 11.53 |
| 97,709 |
| 323,362 |
| 25,488 |
| 395,583 |
| 2024 |
|---|
| 470,006 |
| - |
| 30,307 |
| 25,671 |
| - |
| 26.52 |
| 5.46 |
| 49,472 |
| 71,326 |
| 35,788 |
| 85,010 |
| 2025 |
|---|
| 207,977 |
| 207,977 |
| -3,649 |
| -3,649 |
| -3,649 |
| 20.36 |
| -1.75 |
| 5,823 |
| 106,899 |
| 44,257 |
| 68,465 |
Register and
explore Okredo data| 2025 |
|---|
| 207,977 |
| 207,977 |
| -3,649 |
| -3,649 |
| -3,649 |
| 20.36 |
| -1.75 |
| 5,823 |
| 106,899 |
| 44,257 |
| 68,465 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
207,977 €-56 % *
Sales per employee (€)
207,977 €- *
Profit before tax (€)
-3,649 €-112 % *
Net Profit (€)
-3,649 €-114 % *
Profit per employee (€)
-3,649 €- *
Total profitability (%)
20.36 %-23.23 % *
Net profitability (%)
-1.75 %-132.05 % *
Equity (€)
5,823 €-88 % *
Amounts Payable And Liabilities (€)
106,899 €50 % *
Non-current Assets (€)
44,257 €24 % *
CurrentAssets (€)
68,465 €-19 % *
